Substituted thieno[3,2-d]pyrimidine PIM kinase inhibitors as cancer chemotherapeutics
US8148384B2 · kind B2 · utility
6Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2007 |
| Grant date | Apr 3, 2012 |
| Priority date | — |
| Expiry date | Dec 30, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula Iwherein A1, A2, and A3 are as defined herein are inhibitors of PIM kinase. The compounds of formula I are useful for the treatment of diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.